Page 14 - Peter Loftus News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Sharry Whitney always will remember Clinton resident Richard Enders in his lawyer dress shoes walking across muddy cow pastures while filming the TV program "Mohawk Valley Living." Enders, 79, who died Thursday, hosted "Mohawk Valley Living," which Whitney and her husband, Lance, produced since 2005 as a weekly program on WKTV and more recently as a monthly program. Enders also was well known in the area as a lawyer, the Oneida County district attorney from 1971 to 1981, and star of the Players of Utica's “Scrooge, The Musical” for 28 years. As host of Mohawk Valley Living, Enders alwa...

Provided by Dow Jones By Peter Loftus U.S. health authorities recommended a pause in the use of Johnson & Johnson's Covid-19 vaccine in order to investigate rare but severe cases of blood clots. The U.S. Food and Drug Administration and the U.S. Centers for Disease Control and Prevention announced the move Tuesday, after finding that six women between the ages of 18 and 48 years who got the vaccine had developed blood clots. More than 6.8 million doses have been administered in the U.S., the agencies said. A panel of outside experts will meet Wednesday to ...

By Jared S. Hopkins Pfizer Inc. and BioNTech SE asked U.S. health regulators to allow their Covid-19 vaccine to be given to adolescents, which could make the shots available to kids in the coming weeks. The companies said Friday that they asked the U.S. Food and Drug Administration to extend their shot's use to children 12 years and older. The companies also said they planned to make similar requests to regulators in other countries. The Pfizer-BioNTech vaccine is currently authorized in the U.S. for people 16 years and older. Shots from Moderna Inc. and Johnson & Johnson ar...

By Peter Loftus Deliveries of Johnson & Johnson's Covid-19 vaccine doses throughout the U.S. are expected to plunge by more than 80% next week, according to state officials and federal data, as J&J grapples with manufacturing challenges. The federal government has allocated just 700,000 doses of J&J's vaccine to U.S. states, territories and certain cities and federal agencies next week, compared with 4.9 million doses that were allocated for this week, according to information posted online by the Centers for Disease Control and Prevention. The expected sharp decrease will c...

By Peter Loftus Johnson & Johnson's Covid-19 vaccine was authorized for use in the U.S. by federal health regulators in late February and supplies of doses are ramping up. It is the third shot to be cleared after vaccines from Pfizer Inc. and its partner BioNTech SE and from Moderna Inc. And it is the first shot requiring just one dose, rather than two. Here's what we know and don't know: How do the three Covid-19 vaccines compare? They all work well, health experts say. The Pfizer-BioNTech and Moderna shots were more than 94% effective at preventing Covid-19 in their late-stage t...